12,372 trials
Churg-Strauss Syndrome
Primary: Number of Participants in Each Category of Accrued Duration of Remission — 55; 32; 8; 8 Participants — p=<0.001
Rheumatoid Arthritis
Primary: Percentage of Participants Achieving Sustained Clinical Remission, Disease Activity Scale 28 - Erythrocyte Sedimentation Rate <26 (DAS28-ESR <2.6) at Week 20 and Week 24…
Ischemic Stroke
Primary: Incidence Rate of Stroke and TIA — 2.56; 2.65 events /100 person-years — p=0.8234
HIV Infections
Primary: HIV Seroconversion — 48; 83 Participants — p=0.002
Colitis, Ulcerative
Primary: Induction of Clinical Remission — 44.4; 46.5 Percentage of participants
Nasal Polyps
Primary: Adverse Events — 169 Participants
Cervical Cancer · Endometrial Cancer · Gastrointestinal Complications
Primary: Acute Gastrointestinal Toxicity, as Measured by Change in Expanded Prostate Cancer Index Composite (EPIC) Bowel Domain Score at 5 Weeks From the Start of Pelvic…
Cognition · Aging
Primary: Mean Change From Baseline on the the Benton Visual Retention Test Scores by Treatment Group — -0.73; -1.41 Number of errors
Wounds
Primary: Intra-individual Difference in Time to Wound Closure — -1.4 days — p=<0.0001
Diabetes · Diabetes Mellitus, Type 2
Primary: Change in HbA1c (Glycosylated Haemoglobin) — -1.47; -1.56; -0.00 Percentage of HbA1c — p=< 0.0001
Metastatic Breast Cancer
Primary: Objective Response Rate (ORR) Derived From Central Radiology Assessments: ITT Population — 62.5; 66.5 percentage of participants
Herpes Zoster
Primary: Number of Subjects With Confirmed Herpes Zoster (HZ) Episode — 49; 135 Participants — p=<0.0001
Diabetes · Diabetes Mellitus, Type 1
Primary: Change From Baseline in HbA1c (Glycosylated Haemoglobin) — 7.62; 7.63; 7.58; 7.31 Percentage of glycosylated haemoglobin
Brain and Central Nervous System Tumors
Primary: Overall Survival — 9.33; 7.62 Months
Obsessive-compulsive Disorder
Primary: Children's Yale-Brown Obsessive-Compulsive Scale. — 13.53; 13.98 units on a scale